A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe

• Published in: Parasites & vectors Vol. 11; no. 1; pp. 410 - 10
• Main Authors: Cavalleri, Daniela, Murphy, Martin, Seewald, Wolfgang, Nanchen, Steve
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13.07.2018; BioMed Central; BMC
• Subjects: Allergies; Animals; Assessments; Cat Diseases - drug therapy; Cats; Control; Credelio; Ctenocephalides felis; Dermatitis; Dermatitis - drug therapy; Dermatitis - parasitology; Dermatitis - veterinary; Dogs; Dosage; Drug Combinations; Effectiveness; Evaluation; Female; Field; Field study; Fipronil; Fipronil/(S)-methoprene; Flea Infestations - drug therapy; Flea Infestations - veterinary; Fleas; France; Frontline; Households; Insecticides; Insecticides - adverse effects; Insecticides - therapeutic use; Isoxazoles - adverse effects; Isoxazoles - therapeutic use; Ixodes ricinus; Laboratories; Libraries; Lotilaner; Male; Methoprene; Methoprene - adverse effects; Methoprene - therapeutic use; Parasitology; Pesticides; Pets; Pruritus; Pyrazoles - adverse effects; Pyrazoles - therapeutic use; Randomization; Safety; Safety and security measures; Siphonaptera; Spain; Tablets; Ticks; Treatment Outcome; Veterinary medicine; Europe; France; United States > US; Spain; Field; Fipronil/(S)-methoprene; Credelio; Europe; Cat; Frontline; Efficacy; Safety; Fleas; Lotilaner

Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats and dogs. Its safety, rapid killing onset of action and sustained speed of fleas and ticks kill for a minimum of one month after administration, were demonstrated in a number of laboratory studies in cats. This study was p...